高级检索
当前位置: 首页 > 详情页

The Role of Thioredoxin-1 in Suppression Sepsis Through Inhibiting Mitochondrial-Induced Apoptosis in Spleen

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]College of Life Science and Technology, Kunming University of Science and Technology, Kunming, China [2]Medical Faculty, Kunming University of Science and Technology, Kunming, China [3]The Emergency Intensive Care Unit, The First People’s Hospital of Yunnan Province, Kunming, China
出处:
ISSN:

关键词: Apoptosis endoplasmic reticulum stress mitochondria sepsis thioredoxin-1

摘要:
Sepsis is a serious public health issue and the leading cause of death in critically ill patients in intensive care units. Thioredoxin-1 (Trx-1) is a protein of regulating redox, as well as a modulator of inflammation and apoptosis. Our previous study reported that Trx-1 decreased endoplasmic reticulum-mediated inflammation involved in lung in a model of experimental sepsis. However, its effect on mitochondrial-mediated apoptosis in spleen has not been reported. We studied whether Trx-1 could prevent spleen cells apoptosis in sepsis. In the present study, we showed that the apoptosis in spleen was decreased in sepsis induced by cecal ligation and puncture (CLP) in Trx-1 overexpression transgenic (Tg) mice compared with wild-type mice. Colony forming units in the peritoneal cavity and the level of procalcitonin in plasma were significantly decreased in Trx-1 Tg mice 12h after CLP. The expressions of c-jun-N-terminal kinase, Bax, caspase-9, and caspase-3 were increased in spleen, which were suppressed in Trx-1 Tg mice. However, the decreased Bcl-2 expression in sepsis was recovered in Trx-1 Tg mice. Our results suggest that overexpression of Trx-1 provides protection against sepsis through suppressing mitochondria-induced apoptosis pathway in spleen. This study may provide a new target for clinical intervention, as well potential strategies for treatment of sepsis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 2 区 外科 3 区 危重病医学 3 区 血液学 3 区 外周血管病
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 血液学 3 区 外周血管病 3 区 外科 4 区 危重病医学
JCR分区:
出版当年[2016]版:
Q1 SURGERY Q2 CRITICAL CARE MEDICINE Q2 PERIPHERAL VASCULAR DISEASE Q2 HEMATOLOGY
最新[2023]版:
Q1 SURGERY Q2 CRITICAL CARE MEDICINE Q2 HEMATOLOGY Q2 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]College of Life Science and Technology, Kunming University of Science and Technology, Kunming, China [2]Medical Faculty, Kunming University of Science and Technology, Kunming, China [3]The Emergency Intensive Care Unit, The First People’s Hospital of Yunnan Province, Kunming, China
通讯作者:
通讯机构: [2]Medical Faculty, Kunming University of Science and Technology, Kunming, China [*1]Medical Faculty, Kunming University of Science and Technology, No.727 Jingming South Road, Kunming 650500, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82482 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号